Deliberate Solutions Inc.
New York, NY
- UEI
- JEAGCLNNLEA7
- CAGE
- 8HD07
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1890 Adam Clayton Powell Jr Blvd #5c, New York, NY 10026, USA
- Website
- deliberate.ai
- Founded
- 2020
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Icahn School Of Medicine At Mount Sinai | UF1MH136535 | $171,969 | |
| Icahn School Of Medicine At Mount Sinai | U01MH136535 | $309,043 |
Similar vendors
About the company
Deliberate Solutions Inc., a for-profit corporation based in New York, acts as a prime recipient and sub-recipient of federal research grants focused on artificial intelligence and machine learning applications in mental health and clinical drug development, with no federal contract prime or sub-award history in the source data.
Deliberate Solutions operates exclusively in the federal research-grant space, not in federal contracting. The vendor's footprint centers on two federal agencies — the National Institute of Mental Health (NIMH) under the National Institutes of Health and the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) — representing 100% of recent awards over the past two years. As a prime grant recipient, Deliberate Solutions holds a $1.415 million SBIR Phase II award from NIMH (Mental Health Research Grants, CFDA 93.242) issued August 5, 2026, for technical development and clinical validation of AI-Clinical Outcome Assessment (AI-COA), a multimodal AI tool designed to provide objective measurement of depression severity in clinical trials and advance the tool toward FDA qualification as a drug development tool; work runs through July 31, 2027. The vendor also holds a cooperative agreement from CDER issued February 20, 2024, focused on progressing depression and anxiety AI-COA toward regulatory qualification through expanded dataset development, model performance evaluation, and cross-sex generalization testing; that award concluded January 19, 2026.
In the sub-recipient role, Deliberate Solutions delivers multimodal machine learning and audiovisual data analysis expertise to the Icahn School of Medicine at Mount Sinai on two related federal grants. The first sub-award, issued August 23, 2026, supports the PREDICTOR project, which aims to characterize behavioral phenotypes in adolescents and young adults with potential mental health issues through continuous passive sensing, ecological momentary assessments, and audiovisual feature extraction. A second PREDICTOR sub-award to Mount Sinai issued December 4, 2024. Across both roles, Deliberate Solutions' concrete capability is machine-learning-based analysis of audiovisual clinical interview data, multimodal feature extraction, quality assurance implementation, and algorithm development for depression and anxiety severity measurement. Combined potential value across all four awards totals $2.4 million, with one award facing completion in the next twenty-four months.
Quick answers
Is Deliberate Solutions Inc. registered in SAM.gov?
Yes. Deliberate Solutions Inc.'s SAM.gov registration is active through March 6, 2027.
What is Deliberate Solutions Inc.'s CAGE code?
Deliberate Solutions Inc.'s CAGE code is 8HD07, and its Unique Entity ID (UEI) is JEAGCLNNLEA7.
What is Deliberate Solutions Inc.'s most recent federal award?
Deliberate Solutions Inc.'s most recent federal grant award is AI-clinical outcome assessment (AI-COA) for depression: an innovative drug development tool - depression is a major… (R44MH140727), from National Institute of Mental Health (NIH), on August 5, 2026.
On GovTribe
See Deliberate Solutions Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors